Blog - Page 4138 of 5440

SundayNov 02, 2008 9:09 am

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI)

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) is focused on commercializing patent-protected disruptive healthcare technologies specifically designed to take leading roles for the treatment of a broad array of chronic, debilitating and life-threatening diseases including respiratory, autoimmune and cancer indications. The company anticipates building significant value for its shareholders while meeting its objectives. For further information, visit the Company's web site at www.accentia.net.

SundayNov 02, 2008 9:08 am

ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD)

ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), a biopharmaceutical company, is focused on utilizing innovative technology to stimulate drug discovery and clinical development of novel treatments for central nervous system disorders. The company is currently developing a portfolio of its four most advanced product candidates, all of which originate from discoveries made using ACADIA’s proprietary drug discovery platform. For further information, visit the Company's web site at www.acadia-pharm.com.

SundayNov 02, 2008 9:04 am

Aastrom Biosciences, Inc. (NASDAQ: ASTM)

Aastrom Biosciences, Inc. (NASDAQ: ASTM) is focused on the development of autologous cell products for the repair or regeneration of human tissue. The Company's proprietary Tissue Repair Cell (TRC) technology utilizes a patient's own cells to create products to treat an array of chronic diseases as well as serious injuries. Currently, Aastrom is conducting a Phase II clinical trial with dilated cardiomyopathy (DCM) patients (the IMPACT-DCM trial) and a Phase IIb clinical trial with critical limb ischemia patients (the RESTORE-CLI trial). For further information, visit the Company's web site at www.aastrom.com.

SundayNov 02, 2008 9:03 am

A.P. Pharma, Inc. (NASDAQ: APPA)

A.P. Pharma, Inc. (NASDAQ: APPA), a specialty pharmaceutical company, is committed to developing ethical (prescription) pharmaceuticals through the utilization of its proprietary polymer-based drug delivery systems. The Company's main focus is on developing and commercializing its bioerodible injectable and implantable systems under the trade name Biochronomer™. For further information, visit the Company's web site at www.appharma.com.

SundayNov 02, 2008 5:06 am

Kona Grill, Inc. (KONA) Announces Third Quarter Financial Results; CEO Comments on Fourth Quarter and Year-End Outlook

Kona Grill, Inc. (NASD: KONA), an American grill and sushi bar, recently announced its financial results for the third quarter ended September 30, 2008. Restaurant sales from continuing operations increased 4.3 percent to $19.5 million from $18.7 million during the corresponding quarter in 2007. The increase in restaurant sales during the third quarter reflects additional revenue from three stores opened since November 2007. The company expects fourth quarter sales to range between $19.3 million to $19.8 million with a net loss from continuing operations of $1.2 million to $1.5 million, or a net loss of $0.18 to $0.23 per diluted…

SundayNov 02, 2008 5:04 am

Provectus Pharmaceuticals, Inc. (PVCT.OB) Introduces New Center as Phase 2 Begins for Leading Oncology Agent

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT) announced that they have commenced recruitment for their Phase 2 clinical trial of the company's lead oncology agent PV-10 at a fifth major center, now covering the northeastern United States. The new center joins the other company's centers located in Sydney, Brisbane and Adelaide, Australia, and Houston, Texas. Sanjiv Agarwala, M.D. has been appointed as the principal investigator at the new center, located at St. Luke's Hospital & Health Network, in Bethlehem, PA. Over the next several months, the company intends to continue expansion of the study to include sites in other major population…

FridayOct 31, 2008 12:43 pm

Wall Street Ends Worst Month in 21 Years on High Note

As the closing bell rang on Friday, it marked the end of the worst month that the stock market has seen since 1987. For investors, October 2008 is not a month that will be looked upon with great nostalgia in years to come, however, despite the release of a report that reflected the fears of hesitant consumers, indices rose significantly. The Dow Jones closed at 9,325; up 144 points or 1.57 percent on the day. Let us hear your thoughts below:

FridayOct 31, 2008 12:42 pm

No Federal Financing for GM-Chrysler Merger

Even as the government hands bailout-money to a slew of American banks and insurance providers, it is now refusing to provide GM and Chrysler with funding for a proposed merger. Word came from Bernanke and the Bush administration early on Friday, and it appears that for now, the deal is on hold. Nissan has been flagged as another possibility for Chrysler, as both automakers continue to struggle in a harsh economic environment. Let us hear your thoughts below:

FridayOct 31, 2008 12:40 pm

AgFeed Industries, Inc. (FEED) – China’s Largest Feed Corporation

The Chinese commercial hog farm industry is the largest in the world, accounting for more than half the annual global production. AgFeed Industries is China's largest premix feed company, and has been named one of China's top ten hog producers. Founded in 1995, AgFeed produces well over 600,000 hogs a year at its 28 farms, with the help of more than 1,500 employees. The company also owns five premix feed plants, which are located in some of China's most profitable feed markets. These facilities ship feed to 900 independently owned and operated retail chain stores, as well as provide for…

FridayOct 31, 2008 10:46 am

China Organic Agriculture Inc. (CNOA.OB) Announces Completion of Strategic Acquisition to Gain Foothold in China’s Agricultural Market

China Organic Agriculture Inc. (OTCBB: CNOA) trades agricultural products in China and has established a business plan that will enable it to capitalize on China’s growing consumer class. The company today announced the $10.6 million acquisition of 60% of Dalian Huiming Industry Ltd., a major agricultural trading company with a wide distribution, which will allow China Organic to boost its distribution capabilities. “The completion of this acquisition marks an important milestone in the history of China Organic Agriculture,” Jinsong Li, China Organic’s CEO stated in the press release. “We’re now able to focus on the successful integration of Dalian Huiming…

Site Search

Company Search